These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29914167)

  • 1. STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.
    Laudisi F; Cherubini F; Monteleone G; Stolfi C
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy.
    Yeh JE; Frank DA
    ChemMedChem; 2016 Apr; 11(8):795-801. PubMed ID: 26662504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
    Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
    Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BART is essential for nuclear retention of STAT3.
    Muromoto R; Sekine Y; Imoto S; Ikeda O; Okayama T; Sato N; Matsuda T
    Int Immunol; 2008 Mar; 20(3):395-403. PubMed ID: 18234692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 activation in infection and infection-associated cancer.
    Lu R; Zhang YG; Sun J
    Mol Cell Endocrinol; 2017 Aug; 451():80-87. PubMed ID: 28223148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting transcription factor STAT3 for cancer prevention and therapy.
    Chai EZ; Shanmugam MK; Arfuso F; Dharmarajan A; Wang C; Kumar AP; Samy RP; Lim LH; Wang L; Goh BC; Ahn KS; Hui KM; Sethi G
    Pharmacol Ther; 2016 Jun; 162():86-97. PubMed ID: 26478441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
    Germain D; Frank DA
    Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J; Jove R
    Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting STAT3 in gastric cancer.
    Giraud AS; Menheniott TR; Judd LM
    Expert Opin Ther Targets; 2012 Sep; 16(9):889-901. PubMed ID: 22834702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.
    Yuan J; Zhang F; Niu R
    Sci Rep; 2015 Dec; 5():17663. PubMed ID: 26631279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
    Siveen KS; Sikka S; Surana R; Dai X; Zhang J; Kumar AP; Tan BK; Sethi G; Bishayee A
    Biochim Biophys Acta; 2014 Apr; 1845(2):136-54. PubMed ID: 24388873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.
    Linher-Melville K; Singh G
    Mol Cell Endocrinol; 2017 Aug; 451():40-52. PubMed ID: 28202313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 transcription factor as target for anti-cancer therapy.
    Mohassab AM; Hassan HA; Abdelhamid D; Abdel-Aziz M
    Pharmacol Rep; 2020 Oct; 72(5):1101-1124. PubMed ID: 32880101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy.
    Tolomeo M; Cascio A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 the oncogene - still eluding therapy?
    Wake MS; Watson CJ
    FEBS J; 2015 Jul; 282(14):2600-11. PubMed ID: 25825152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
    Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and functional interactions between STAT3 and KAP1.
    Tsuruma R; Ohbayashi N; Kamitani S; Ikeda O; Sato N; Muromoto R; Sekine Y; Oritani K; Matsuda T
    Oncogene; 2008 May; 27(21):3054-9. PubMed ID: 18037959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Buettner R; Mora LB; Jove R
    Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.